Skip to main content
logo
Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.400
-0.080 (-3.23%)
At close: Jun 5, 2026, 4:00 PM EDT
2.390
-0.010 (-0.42%)
After-hours: Jun 5, 2026, 6:22 PM EDT

Ovid Therapeutics Revenue

Ovid Therapeutics had revenue of $7.12M in the twelve months ending March 31, 2026, up 1,199.64% year-over-year. In the year 2025, Ovid Therapeutics had annual revenue of $7.25M with 1,181.27% growth.

Revenue (ttm)
$7.12M
Revenue Growth
+1,199.64%
P/S Ratio
62.89
Revenue / Employee
$309,652
Employees
23
Market Cap
447.94M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.25M6.69M1,181.27%
Dec 31, 2024566.00K174.00K44.39%
Dec 31, 2023392.00K-1.11M-73.91%
Dec 31, 20221.50M-206.88M-99.28%
Dec 31, 2021208.38M195.77M1,551.58%
Dec 31, 202012.62M--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sutro Biopharma99.61M
Autolus Therapeutics92.62M
Prothena Corporation57.94M
Editas Medicine38.69M
C4 Therapeutics34.86M
Adlai Nortye5.00M
Ocugen4.47M
Revenue Rankings

OVID News

More News